Due to unforeseen circumstances, The Anatomy of the Smile Webinar sponsored by pharmaceutical company Galderma has been postponed until March 11.
The Food and Drug Administration (FDA) has approved Restylane Refyne and Restylane Defyne dermal fillers from Galderma for the treatment of nasolabial folds.
Pharmaceutical company Galderma (UK) Limited has confirmed that aesthetic and skincare product supplier Med-fx Ltd will become the company’s preferred distributor, subject to contract, for its aesthetics portfolio.
On September 9, senior leaders of pharmaceutical company Galderma UK and Ireland and aesthetic product distributor Med-fx met for the official unveiling of their partnership at the Med-fx headquarters in Witham, Essex.
The US Food and Drug Administration (FDA) has approved hyaluronic acid dermal filler Restylane Lyft for cheek augmentation and the correction of age-related mid-face contour deficiencies via small blunt tip cannula in patients over the age of 21.
Pharmaceutical company Galderma (UK) Limited and aesthetic and skincare product supplier Med-fx Ltd will launch new, enhanced packages of customer-centric support services for healthcare professionals who purchase products marketed under the Azzalure and Restylane brands in the UK and Ireland from September 8.
Aesthetics reports on the Galderma Aesthetics Academy Annual Conference.
Pharmaceutical company Galderma will be hosting a free, two-hour webinar on the Aesthetics Media website between 7-9pm on March 11.
Aesthetic distributor Fusion GT has introduced the Carbomix device that combines carboxytherapy and hyperbaric oxygen therapy.
Dermatology pharmaceutical company, Galderma, has announced a US nationwide collaboration with aesthetic medicine company best know for breast aesthetics and reconstruction, Mentor Worldwide LLC.